Literature DB >> 11297263

UCN-01 suppresses E2F-1 mediated by ubiquitin-proteasome-dependent degradation.

C T Hsueh1, Y C Wu, G K Schwartz.   

Abstract

E2F-1 regulates the transcription of genes required for DNA synthesis. Previously, we have reported that UCN-01 suppresses E2F-1 protein expression without any noticeable effect on its mRNA level in gastric cancer cell line SK-GT5 (Clin. Cancer Res., 4: 2201-2206, 1998). In this study, we investigated the mechanism responsible for the suppression of E2F-1 expression by UCN-01 in SK-GT5 cells. After 24-h exposure to 1 microM UCN-01, E2F-1 protein expression was decreased by >99%. The suppressive effect of UCN-01 could be reversed by ubiquitin-dependent proteasome inhibitors such as calpain inhibitor I and lactacystin. Transfection experiments using expression plasmids encoding full-length E2F-1 or truncated E2F-1 with deletion of the COOH-terminal region (which is required for eliciting ubiquitination and protein degradation) revealed that the expression of truncated E2F-1 was not affected by UCN-01. Other cell-cycle-related and ubiquitin-proteasome-regulated proteins such as p21, p27, and cyclin B1 were not repressed by UCN-01 in E2F-1-overexpressing cells. In vitro-translated, full-length E2F-1 degraded more rapidly upon incubation with extracts from UCN-01-treated cells when compared with truncated E2F-1. Taken together, these data indicate that UCN-01 suppresses E2F-1 protein expression mediated by the ubiquitin-proteasome pathway in a specific manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297263

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  7 in total

Review 1.  Protein kinase C inhibitors.

Authors:  Helen C Swannie; Stanley B Kaye
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

2.  Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats.

Authors:  Kae Won Cho; Yong Ook Kim; Juan E Andrade; John R Burgess; Young-Cheul Kim
Journal:  Eur J Nutr       Date:  2010-06-23       Impact factor: 5.614

3.  UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.

Authors:  Tatjana Mijatovic; Tina Mahieu; Céline Bruyère; Nancy De Nève; Janique Dewelle; Gentiane Simon; Mischaël J M Dehoux; Ellen van der Aar; Benjamin Haibe-Kains; Gianluca Bontempi; Christine Decaestecker; Eric Van Quaquebeke; Francis Darro; Robert Kiss
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

4.  Deprivation of arginine by recombinant human arginase in prostate cancer cells.

Authors:  Eddy C Hsueh; Stephanie M Knebel; Wai-Hung Lo; Yun-Chung Leung; Paul Ning-Man Cheng; Chung-Tsen Hsueh
Journal:  J Hematol Oncol       Date:  2012-04-30       Impact factor: 17.388

5.  The role of bile acids in cellular invasiveness of gastric cancer.

Authors:  Yu-Chung Wu; Chang-Fang Chiu; Chung-Tzu Hsueh; Chung-Tsen Hsueh
Journal:  Cancer Cell Int       Date:  2018-05-21       Impact factor: 5.722

6.  Clinical significance of E2F1 protein expression in non-small cell lung cancer.

Authors:  Jung-Jyh Hung; Chung-Tsen Hsueh; Kuan-Hua Chen; Wen-Hu Hsu; Yu-Chung Wu
Journal:  Exp Hematol Oncol       Date:  2012-07-20

7.  Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer.

Authors:  Benjamin B Mull; J Andrew Livingston; Nalini Patel; Tuyen Bui; Kelly K Hunt; Khandan Keyomarsi
Journal:  Br J Cancer       Date:  2020-01-16       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.